Answers are grounded in this paper and cite their sources.
Despite an extensive literature reporting on SARS treatments, it was not possible to determine whether treatments benefited patients during the SARS outbreak. Some may have been harmful. Clinical trials should be designed to validate a standard protocol for dosage and timing, and to accrue data in real time during future outbreaks to monitor specific adverse effects and help inform treatment.
No takes yet. Share an insight, caveat, or question.
Stockman et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: